Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xingyun Cai

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Urology|March 25, 2022
Cognitive Function After Cardiopulmonary Bypass and Deep Hypothermic Circulatory Arrest in Management of Renal Cell Carcinoma With Vena Caval ThrombusXingyun Cai, Jiwei Huang, Xiaoying Yao, et al.
Frontiers in Immunology|May 25, 2026
The immune dysregulation landscape and dynamic regulation of competing endogenous RNAs in spinal cord injuryYuxuan Yao, Wenliang Guo, Xingyun Cai, et al.
International Journal of Nanomedicine|August 6, 2021
Dual Targeting of Endoplasmic Reticulum by Redox-Deubiquitination Regulation for Cancer TherapyBiao Cai, Mengfei Hou, Shijun Zhang, et al.
Frontiers in Oncology|March 14, 2022
Prospective Clinical Trial of the Oncologic Outcomes and Safety of Extraperitoneal Laparoscopic Extended Retroperitoneal Lymph Node Dissection at Time of Nephroureterectomy for Upper Tract Urothelial CarcinomaJiwei Huang, Hongyang Qian, Yichu Yuan, et al.
The Journal of Urology|March 18, 2025
Reply by AuthorsJiwei Huang, Xingyun Cai, Cheoklong Ng, et al.
The Journal of Urology|February 25, 2025
A Phase 2 Study of Tislelizumab as Neoadjuvant Treatment of Cisplatin-Ineligible High-Risk Upper Tract Urothelial CarcinomaJiwei Huang, Xingyun Cai, Cheoklong Ng, et al.
The Journal of Urology|March 14, 2025
Reply by AuthorsJiwei Huang, Xingyun Cai, Cheoklong Ng, et al.
Cancer Medicine|March 23, 2023
Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world studyRuopeng Su, Zeyu Chen, Daoping Hong, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Urology|March 25, 2022
Cognitive Function After Cardiopulmonary Bypass and Deep Hypothermic Circulatory Arrest in Management of Renal Cell Carcinoma With Vena Caval ThrombusXingyun Cai, Jiwei Huang, Xiaoying Yao, et al.
Frontiers in Immunology|May 25, 2026
The immune dysregulation landscape and dynamic regulation of competing endogenous RNAs in spinal cord injuryYuxuan Yao, Wenliang Guo, Xingyun Cai, et al.
International Journal of Nanomedicine|August 6, 2021
Dual Targeting of Endoplasmic Reticulum by Redox-Deubiquitination Regulation for Cancer TherapyBiao Cai, Mengfei Hou, Shijun Zhang, et al.
Frontiers in Oncology|March 14, 2022
Prospective Clinical Trial of the Oncologic Outcomes and Safety of Extraperitoneal Laparoscopic Extended Retroperitoneal Lymph Node Dissection at Time of Nephroureterectomy for Upper Tract Urothelial CarcinomaJiwei Huang, Hongyang Qian, Yichu Yuan, et al.
The Journal of Urology|March 18, 2025
Reply by AuthorsJiwei Huang, Xingyun Cai, Cheoklong Ng, et al.
The Journal of Urology|February 25, 2025
A Phase 2 Study of Tislelizumab as Neoadjuvant Treatment of Cisplatin-Ineligible High-Risk Upper Tract Urothelial CarcinomaJiwei Huang, Xingyun Cai, Cheoklong Ng, et al.
The Journal of Urology|March 14, 2025
Reply by AuthorsJiwei Huang, Xingyun Cai, Cheoklong Ng, et al.
Cancer Medicine|March 23, 2023
Effectiveness and safety of immune checkpoint inhibitor monotherapy in advanced upper tract urothelial carcinoma: A multicenter, retrospective, real-world studyRuopeng Su, Zeyu Chen, Daoping Hong, et al.
Pageof 1